newsfilter
← Latest News
GlobeNewswire·

Impel Pharmaceuticals to Present at H.C. Wainwright Global Investment Conference

SEATTLE, May 12, 2022 (GLOBE NEWSWIRE) -- Impel Pharmaceuticals Inc. (NASDAQ:IMPL), a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, with an initial focus on